Form 4 for BBNX Beta Bionics, Inc.
Accepted 2025-12-04 00:00:00 ET · period of report 2025-12-02 · accession 0002048500-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-04 | 2025-12-02 | BBNX | Mensinger Mike | Chief Product Off | S - Sale | $29.34 | -1,063 | 90.8K | -1% | -$31.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-02 | S | D | 1,063 | $29.34 | 90,752 | D | — | — |